$VSTM: Verastem Oncology Announces Publication of the Phase 2 …

Date: Thursday, February 14th, 2019

Stock(s) mentioned:

Source: Business Wire (https://www.businesswire.com)

Summary: BOSTON–(BUSINESS WIRE)–Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), a biopharmaceutical company focused on developing and …

Full article address: https://www.businesswire.com/news/home/20190214005211/en/Verastem-Oncology-Announces-Publication-Phase-2-DYNAMO

Related News:

$HTGC $VSTM: Hercules Capital Announces Multiple Outstanding Achievements by …

$VSTM: Here’s Why Verastem Tumbled 34.1% in December

$VSTM: Verastem Oncology Announces Inducement Grants Under Nasdaq …

$VSTM: Verastem Oncology Outlines Strategic Priorities for 2019 and …

$VSTM: Hedge Funds Are Crazy About Verastem Inc (VSTM)

$VSTM: Verastem Oncology Announces First Recipient of the Care …

$CVTI $SLD $VSTM: Is Covenant Transportation Group, Inc. (CVTI) A Good Stock To Buy?

$VSTM: Verastem Oncology Announces Inducement Grants Under Nasdaq …

$VSTM: Verastem Oncology Presents Duvelisib Development Program Data …

$VSTM: Verastem Oncology Announces Presentation of Updated Duvelisib …

$VSTM: Verstem up 6% premarket after Q3 report; duvelisib launch …

Latest News:

$XPO: XPO Logistics Launches New Website Experience

$LMT: Lockheed Martin, Diehl and Saab Unveil Collaboration to Counter …

$SF: Knight Signs GUD (Bueno) Latin American Strategic Funding Deal …

$NE: Noble Corp.: Good Fleet, But High Debt Load Limits Flexibility

$WIT: Wipro Launches QuMiC to Accelerate Migration to Oracle Cloud

$WMT $EBAY: Walmart Reports Earnings: Analysts’ Expectations

$WCG: Passport lawsuit claims state Medicaid cuts could push it to insolvency

$FB $TWTR: Why Is Facebook Up, Twitter Down This Earnings Season?

$XOM: Here’s Why The Best Is Yet to Come for ExxonMobil

$DBX: HomeSign Acquisition Will Help Dropbox Expand Business Segment

$CRUS $AAPL: Does Cirrus Logic Have a Future Beyond Apple?